Paul Basken
May 9, 2017
Not even two months ago, the Trump administration shocked the biomedical research community by proposing an 18-percent cut to the budget of the National Institutes of Health.
On Monday at the White House, that attitude began to look like ancient history.
Ushered into the Executive Mansion by a contingent of biomedical industry chiefs, NIH leaders spent two hours with top administration officials — followed by a visit with President Trump himself — carefully explaining the economic and human-health importance of the federal investment in medical science.
